Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Craig A Erickson

Showing results (71-80 of 158) with videos related to

Pageof 16
Sort By:
Journal of Autism and Developmental Disorders|August 26, 2018
Emotion Regulation Intensive Outpatient Programming: Development, Feasibility, and AcceptabilityRebecca C Shaffer, Logan K Wink, Jennifer Ruberg, et al.
Scientific Reports|March 7, 2023
A sensitive and reproducible qRT-PCR assay detects physiological relevant trace levels of FMR1 mRNA in individuals with Fragile X syndromeDevan Straub, Lauren M Schmitt, Anna E Boggs, et al.
American Journal of Medical Genetics. Part A|June 22, 2016
Analysis of peripheral amyloid precursor protein in Angelman SyndromeCraig A Erickson, Logan K Wink, Bayon Baindu, et al.
Psychopharmacology|February 15, 2011
A prospective open-label study of aripiprazole in fragile X syndromeCraig A Erickson, Kimberly A Stigler, Logan K Wink, et al.
Journal of Child and Adolescent Psychopharmacology|November 2, 2011
Paliperidone palmitate in a child with autistic disorderJanet L Kowalski, Logan K Wink, Kelly Blankenship, et al.
Journal of Child and Adolescent Psychopharmacology|June 13, 2009
Aripiprazole in pervasive developmental disorder not otherwise specified and Asperger's disorder: a 14-week, prospective, open-label studyKimberly A Stigler, Jonathan T Diener, Arlene E Kohn, et al.
Scientific Reports|April 7, 2026
SPG601-associated modulation of resting-state EEG and improvement in executive function in a fragile X syndrome randomized controlled crossover studyErnest V Pedapati, Peter W Vanderklish, Stella T Sarraf, et al.
Brain Research|November 10, 2010
Open-label riluzole in fragile X syndromeCraig A Erickson, Ning Weng, Ivan Jeanne Weiler, et al.
Journal of Child and Adolescent Psychopharmacology|March 18, 2016
Clozapine for Drug-Refractory Irritability in Individuals with Developmental DisabilityLogan K Wink, Ismail Badran, Ernest V Pedapati, et al.
Disability and Health Journal|May 24, 2019
Preventive care services and health behaviors in children with fragile X syndromeKendra E Gilbertson, Hannah L Jackson, Eric J Dziuban, et al.
Pageof 16

Showing results (71-80 of 158) with videos related to

Sort By:
Pageof 16
Journal of Autism and Developmental Disorders|August 26, 2018
Emotion Regulation Intensive Outpatient Programming: Development, Feasibility, and AcceptabilityRebecca C Shaffer, Logan K Wink, Jennifer Ruberg, et al.
Scientific Reports|March 7, 2023
A sensitive and reproducible qRT-PCR assay detects physiological relevant trace levels of FMR1 mRNA in individuals with Fragile X syndromeDevan Straub, Lauren M Schmitt, Anna E Boggs, et al.
American Journal of Medical Genetics. Part A|June 22, 2016
Analysis of peripheral amyloid precursor protein in Angelman SyndromeCraig A Erickson, Logan K Wink, Bayon Baindu, et al.
Psychopharmacology|February 15, 2011
A prospective open-label study of aripiprazole in fragile X syndromeCraig A Erickson, Kimberly A Stigler, Logan K Wink, et al.
Journal of Child and Adolescent Psychopharmacology|November 2, 2011
Paliperidone palmitate in a child with autistic disorderJanet L Kowalski, Logan K Wink, Kelly Blankenship, et al.
Journal of Child and Adolescent Psychopharmacology|June 13, 2009
Aripiprazole in pervasive developmental disorder not otherwise specified and Asperger's disorder: a 14-week, prospective, open-label studyKimberly A Stigler, Jonathan T Diener, Arlene E Kohn, et al.
Scientific Reports|April 7, 2026
SPG601-associated modulation of resting-state EEG and improvement in executive function in a fragile X syndrome randomized controlled crossover studyErnest V Pedapati, Peter W Vanderklish, Stella T Sarraf, et al.
Brain Research|November 10, 2010
Open-label riluzole in fragile X syndromeCraig A Erickson, Ning Weng, Ivan Jeanne Weiler, et al.
Journal of Child and Adolescent Psychopharmacology|March 18, 2016
Clozapine for Drug-Refractory Irritability in Individuals with Developmental DisabilityLogan K Wink, Ismail Badran, Ernest V Pedapati, et al.
Disability and Health Journal|May 24, 2019
Preventive care services and health behaviors in children with fragile X syndromeKendra E Gilbertson, Hannah L Jackson, Eric J Dziuban, et al.
Pageof 16